Speaker illustration

Doctor Nathaniel Mark Hawkins

University of British Columbia, Vancouver (Canada)

Member of:

European Society of Cardiology

Dr Hawkins is a clinician-scientist cardiologist and Associate Professor at UBC with dual training in heart failure and electrophysiology. His leadership roles include Medical Lead for Quality and Research at Cardiac Services BC, Director of Research for the UBC Division of Cardiology, and Physician Lead for the Vancouver Coastal Health Regional Heart Failure Program. His research group examines cardiovascular outcomes, health services, and comorbidities in patients with heart failure, arrhythmia, and pulmonary disease. He has authored or co-authored over 110 publications. He is Co-PI for the MAPLE-CHF and international SYMPHONY heart failure screening trial, member of the CIHR Canadian Heart Function Alliance, and Co-PI for the Canadian Cardiovascular Society MYCOVACC national surveillance study of myocarditis and/or pericarditis following mRNA COVID-19 vaccination.

Increased risk of decompensated heart failure, acute coronary syndrome, arrythmias and ischemic stroke following exacerbation of COPD: results from a multi-database cohort study

Event: ESC Congress 2023

Topic: Cardiovascular Disease in Primary Care

Session: Cardiovascular disease in primary care


Programmed parameters significantly change implantable cardioverter-defibrillator longevity

Event: ESC Congress 2016

Topic: Big data analysis in cardiology, registries and databases

Session: Big data analysis in cardiology, registries and databases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb